Thomas Goetz, Executive Editor of Wired, talks about “information with feeling” and how the future of health is in the hands of the consumer. Follow Thomas Goetz on…
NEW YORK (Reuters Health) – In a randomized, single-center study of critically ill patients in an intensive care unit, permissive enteral underfeeding was associated with lower morbidity and…
NEW YORK (Reuters Health) – Research shows that biliopancreatic diversion (BPD) significantly reduces renal and cardiovascular complications over 10 years in morbidly obese individuals with newly diagnosed type…
NEW YORK (Reuters Health) – In looking back at patients admitted to a medical ICU in Olmsted County, Minnesota in 2006, clinicians found that those who were on…
NEW YORK (Reuters Health) – In metformin-treated patients with type 2 diabetes, exenatide twice daily improves glycemic control to the same degree as insulin aspart twice daily, but…
NEW YORK (Reuters Health) – For patients who require stroke prevention therapy and who also undergo coronary stenting, combining oral anticoagulation with aspirin and clopidogrel provides better antithrombotic…
NEW YORK (Reuters Health) – Compared to the standard 75-mg/d maintenance dose of clopidogrel, 150 mg/d produces greater platelet inhibition, higher flow-mediated vasodilation, and reduced inflammation – all…
NEW YORK (Reuters Health) – Compared with digital subtraction angiography, computed tomographic angiography is only about half as sensitive in identifying cerebrovascular injuries resulting from blunt trauma, reports…
NEW YORK (Reuters Health) – For patients undergoing coronary artery bypass surgery, discontinuing chronic aspirin therapy at least 6 days before or within 5 days of surgery has…
NEW YORK (Reuters Health) – Although quite rare, local reactions to the fifth dose of diphtheria/tetanus/acellular-pertussis (DTaP) vaccine in children are more likely when the vaccine is injected…
NEW YORK (Reuters Health) – For mild persistent asthma, fluticasone propionate with salmeterol cuts the risk of exacerbations more than ciclesonide, but both regimens effectively control daily symptoms.…
NEW YORK (Reuters Health) – In patients with stage 1 and 2 hypertension, the experimental angiotensin receptor blocker (ARB) azilsartan medoxomil lowers blood pressure better than maximal doses…
